𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lentiviral vectors for HIV disease prevention and treatment

✍ Scribed by Franck Lemiale; Nikolay Korokhov

Book ID
116961297
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
294 KB
Volume
27
Category
Article
ISSN
0264-410X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Non-HIV lentiviral vectors
Non-HIV lentiviral vectors
πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 52 KB

In 1995 Professor Kingsman co-founded Oxford BioMedica to develop and commercialise gene technologies arising out of research undertaken by the Group at the University. The company uses advanced gene delivery technologies for the treatment of disease in the areas of oncology, viral infection, neurob

Chimeric HIV-1 and HIV-2 lentiviral vect
Chimeric HIV-1 and HIV-2 lentiviral vectors with added safety insurance
✍ Geetanjali Sachdeva; Jenice D'Costa; Jang E. Cho; Kritika Kachapati; Vidita Chou πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 196 KB

## Abstract Lentiviruses are unique in their ability to infect both dividing and non‐dividing cells. This makes the vectors derived from them particularly useful for gene transfer into non‐dividing cells, including stem cells. Lentiviral vectors are becoming the vectors of choice for si/shRNA deliv

Lentiviral vectors that carry anti-HIV s
Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions
✍ Olivier ter Brake; Ben Berkhout πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 290 KB

## Abstract ## Background HIV‐1 replication can be inhibited with RNA interference (RNAi) by expression of short hairpin RNA (shRNA) from a lentiviral vector. Because lentiviral vectors are based on HIV‐1, viral sequences in the vector system are potential targets for the antiviral shRNAs. Here, w